XLONICON
Market cap734kUSD
Feb 28, Last price
5.25GBP
Name
Iconic Labs PLC
Chart & Performance
P/E
139.87
P/S
—
EPS
0.04
Div Yield, %
0.00%
Shrs. gr., 5y
215.19%
Rev. gr., 5y
54.20%
Revenues
0k
Net income
419k
-91.21%
CFO
-803k
L-12.73%
Earnings
Mar 26, 2025
Profile
Iconic Labs Plc engages in media and technology business, focuses providing online marketing, and content and technology driven products. It also engages in digital and social media publishing activities. The company offers advisory services to clients on their businesses; and delivers campaigns, as well as provides creative services to its clients. Its activities include monthly insights, content creation and distribution, post campaign analysis, and combining with online media brands. The company was formerly known as WideCells Group PLC and changed its name to Iconic Labs Plc in July 2019. Iconic Labs Plc was founded in 2012 and is based in London, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
| Income | ||||||||||
Revenues | 27 -94.73% | |||||||||
Cost of revenue | 4,769 | 249 | ||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (4,769) | (222) | ||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | (4,769) | (222) | ||||||||
Net income | 419 -91.21% | 4,769 -725.72% | (762) -90.10% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | 2,647 | 1,940 | 2,415 | |||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 3,225 | |||||||||
Net debt | 2,517 | 1,890 | 2,415 | |||||||
| Cash flow | ||||||||||
Cash from operating activities | (803) | (920) | (51) | |||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | 882 | 970 | ||||||||
FCF | (1,629) | (9,592) | 437 | |||||||
| Balance | ||||||||||
Cash | 129 | 50 | 5 | |||||||
Long term investments | ||||||||||
Excess cash | 129 | 50 | ||||||||
Stockholders' equity | (15,196) | (16,058) | (20,916) | |||||||
Invested Capital | 15,125 | 14,358 | 14,392 | |||||||
ROIC | ||||||||||
ROCE | 280.52% | 3.40% | ||||||||
| EV | ||||||||||
Common stock shares outstanding | 8,785 | 4,631 | 37,405,248 | |||||||
Price | 0.40 | |||||||||
Market cap | 1,852 | |||||||||
EV | 3,742 | |||||||||
EBITDA | (4,769) | (222) | ||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||